Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$35.61 - $76.23 $141,336 - $302,556
-3,969 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$57.56 - $82.54 $20,606 - $29,549
-358 Reduced 8.27%
3,969 $278,000
Q4 2021

Feb 08, 2022

BUY
$72.5 - $100.68 $18,197 - $25,270
251 Added 6.16%
4,327 $337,000
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $191,940 - $263,854
-2,127 Reduced 34.29%
4,076 $389,000
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $283,321 - $421,291
3,025 Added 95.19%
6,203 $771,000
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $37,185 - $49,448
319 Added 11.16%
3,178 $419,000
Q4 2020

Feb 09, 2021

BUY
$99.61 - $142.12 $25,998 - $37,093
261 Added 10.05%
2,859 $379,000
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $21,948 - $30,705
301 Added 13.1%
2,598 $265,000
Q2 2020

Aug 03, 2020

BUY
$55.75 - $92.75 $128,057 - $213,046
2,297 New
2,297 $200,000
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $126,737 - $349,247
-3,344 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $23,065 - $29,622
297 Added 9.75%
3,344 $309,000
Q3 2019

Nov 12, 2019

SELL
$90.37 - $122.49 $8,494 - $11,514
-94 Reduced 2.99%
3,047 $275,000
Q2 2019

Aug 13, 2019

SELL
$89.51 - $118.04 $170,785 - $225,220
-1,908 Reduced 37.79%
3,141 $371,000
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $88,941 - $138,477
1,435 Added 39.71%
5,049 $437,000
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $40,348 - $59,515
-720 Reduced 16.61%
3,614 $228,000
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $209,288 - $349,320
4,334 New
4,334 $342,000
Q2 2018

Aug 13, 2018

SELL
$37.84 - $69.96 $685,282 - $1.27 Million
-18,110 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$39.82 - $57.53 $102,855 - $148,599
-2,583 Reduced 12.48%
18,110 $730,000
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $454,207 - $591,182
9,770 Added 89.44%
20,693 $1.09 Million
Q3 2017

Nov 13, 2017

BUY
$37.05 - $47.12 $45,238 - $57,533
1,221 Added 12.59%
10,923 $515,000
Q2 2017

Aug 11, 2017

BUY
N/A
9,702
9,702 $343,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.